Examining multimorbidity contributors to dementia over time
- PMID: 39988573
- PMCID: PMC11847647
- DOI: 10.1002/alz.14589
Examining multimorbidity contributors to dementia over time
Abstract
Introduction: Multimorbidity is associated with increased risk of dementia, but previous estimation of the joint contribution of constituent conditions to dementia incidence did not model additive contributions or temporal proximity in the sequential onset of conditions.
Methods: Data were analyzed from 9944 Health and Retirement Study participants and Medicare fee-for-service beneficiaries, ages 68-99, without Alzheimer's disease and related dementias (ADRD) at baseline, from 1998-2016. ADRD and chronic condition were encoded using validated claims algorithms. We estimated the absolute contribution of eight conditions to ADRD with the longitudinal extension of the average attributable fraction (LE-AAF).
Results: Hypertension, acute myocardial infarction, atrial fibrillation, diabetes, heart failure, ischemic heart disease, stroke, and arthritis additively accounted for 71.8% (95% confidence interval [CI]: 62.9%-79.1%) of ADRD incident cases based on LE-AAF.
Discussion: Our findings suggest that multimorbidity plays a pivotal role in ADRD incidence. Targeting constituents of a cardiovascular path to dementia may contribute most to lowering dementia risk.
Highlights: Most dementia cases (71.8%) were attributable to eight chronic conditions. Hypertension was the largest contributor to dementia risk. Confidence intervals were smallest for constituents of a cardiovascular path to dementia. Longitudinal extension of the average attributable fractions (LE-AAFs) explicitly consider longitudinal patterns of comorbidities. Acute myocardial infarction did not contribute significantly to dementia incidence.
Keywords: ADRD; Alzheimer's disease and related dementias; longitudinal extension of the average attributable fraction ( LE‐AAF); multimorbidity; population attributable fraction ( PAF); population attributable risk.
© 2025 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
The authors declare no conflicts of interest. Author disclosures are available in the Supporting Information.
Figures
References
-
- Kivipelto M, Barbera M, de Jager CA, et al. From FINGER to MET‐FINGER: metformin and lifestyle intervention for multimodal precision prevention of dementia. Alzheimers Dement. 2022;18:e061539. doi:10.1002/alz.061539 - DOI
MeSH terms
Grants and funding
- P30 AG066508/AG/NIA NIH HHS/United States
- R33AG057806/National Institute on Aging at the National Institutes of Health
- P30AG066508/Yale Alzheimer's Disease Research Center
- P30 AG021342/AG/NIA NIH HHS/United States
- RF1 AG058545/AG/NIA NIH HHS/United States
- R33 AG057806/AG/NIA NIH HHS/United States
- P30AG021342/National Institute on Aging at the National Institutes of Health
- R01 AG047891/AG/NIA NIH HHS/United States
- RF1AG058545/National Institute on Aging at the National Institutes of Health
- R01AG047891/National Institute on Aging at the National Institutes of Health
- 803239/European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme
LinkOut - more resources
Full Text Sources
Medical
